Table of Content

1. Introduction
1.1. Research Process
1.2. Assumption
1.3. Market Segmentation
1.4. Market Definition

2. Executive Summary

3. Expert Verbatim- What our Experts Say?

4. Impact of IOT, AI, IR & VR on Global Artificial Intelligence (AI) Enabled Imaging Modalities Market

5. Material Advancements in Global Artificial Intelligence (AI) Enabled Imaging Modalities Market

6. Global Artificial Intelligence (AI) Enabled Imaging Modalities Market Policies, Regulations, Technology Standards

7. Global Artificial Intelligence (AI) Enabled Imaging Modalities Market Trends & Insights

8. Global Artificial Intelligence (AI) Enabled Imaging Modalities Market Dynamics
8.1. Growth Drivers
8.2. Challenges
8.3. Impact Analysis

9. Global Artificial Intelligence (AI) Enabled Imaging Modalities Market Hotspot and Opportunities

10. Global Artificial Intelligence (AI) Enabled Imaging Modalities Market Key Strategic Imperatives for Success and Growth

11. Global Artificial Intelligence (AI) Enabled Imaging Modalities Market Start-up Ecosystem, 2016-2021
11.1. Entrepreneurial Activity
11.2. Year on Year Funding Received
11.3. Funding Received by Top Companies
11.4. Key Investors Active in the Market
11.5. Series Wise Funding Received
11.5.1. Seed Funding
11.5.2. Angel Investing
11.5.3. Venture Capital
11.5.4. Others

12. Global Artificial Intelligence (AI) Enabled Imaging Modalities Market Value Chain Analysis

13. Global Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
13.1. Market Size and Analysis
13.1.1. By Revenues
13.2. Market Share and Analysis
13.2.1. By Component
13.2.1.1. By Software Type
13.2.1.1.1. AI Software Algorithms
13.2.1.1.2. Real Time Medical Imaging
13.2.1.1.3. Image Analysis
13.2.1.1.4. Predictive Analysis Solution
13.2.1.1.5. Intelligent Algorithms For Image Analysis
13.2.1.1.6. Data Mining Techniques
13.2.1.2. By Hardware
13.2.1.2.1. By Processor
13.2.1.2.1.1. GPU
13.2.1.2.1.2. MPU
13.2.1.2.1.3. ASIC
13.2.1.2.1.4. FPGA
13.2.1.2.2. By Network
13.2.1.2.3. By Memory
13.2.1.3. By Services
13.2.1.3.1. Installation
13.2.1.3.2. Support & Maintenance
13.2.1.3.3. Others
13.2.2. By Therapeutic Application
13.2.2.1. Cardiology
13.2.2.2. Oncology
13.2.2.2.1. Breast Cancer
13.2.2.2.2. Lung Cancer
13.2.2.2.3. Other cancer types
13.2.2.3. Neurology
13.2.2.4. Pulmonology
13.2.2.5. Others
13.2.3. By Modality
13.2.3.1. Computed Tomography (CT)
13.2.3.2. Magnetic Resonance (MR)
13.2.3.3. Ultrasound
13.2.3.4. X-Ray
13.2.3.5. Positron Emission Tomography (PET)
13.2.3.6. Other Modalities
13.2.4. By Region
13.2.4.1. North America
13.2.4.2. South America
13.2.4.3. Europe
13.2.4.4. Middle East & Africa
13.2.4.5. Asia-Pacific
13.2.5. By Company
13.2.5.1. Revenue Shares
13.2.5.2. Strategic Factorial Indexing
13.2.5.3. Competitor Placement in MarkNtel Quadrant

14. North America Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
14.1. Market Size and Analysis
14.1.1. By Revenues
14.2. Market Share and Analysis
14.2.1. By Component
14.2.2. By Therapeutic Application
14.2.3. By Country
14.2.3.1. US
14.2.3.2. Canada
14.3. The US Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
14.3.1. Market Size and Analysis
14.3.2. By Revenues
14.3.3. Market Share and Analysis
14.3.3.1. By Therapeutic Application
14.4. Canada Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
14.4.1. Market Size and Analysis
14.4.1.1. By Revenues
14.4.2. Market Share and Analysis
14.4.2.1. By Therapeutic Application

15. South America Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
15.1. Market Size and Analysis
15.1.1. By Revenues
15.2. Market Share and Analysis
15.2.1. By Component
15.2.2. By Therapeutic Application
15.2.3. By Country
15.2.3.1. Brazil
15.2.3.2. Others
15.3. Brazil Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
15.3.1. Market Size and Analysis
15.3.1.1. By Revenues
15.3.2. Market Share and Analysis
15.3.2.1. By Therapeutic Application

16. Europe Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
16.1. Market Size and Analysis
16.1.1. By Revenues
16.2. Market Share and Analysis
16.2.1. By Component
16.2.2. By Therapeutic Application
16.2.3. By Country
16.2.3.1. Germany
16.2.3.2. France
16.2.3.3. UK
16.2.3.4. Russia
16.2.3.5. Rest of Europe
16.3. Germany Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
16.3.1. Market Size and Analysis
16.3.1.1. By Revenues
16.3.2. Market Share and Analysis
16.3.2.1. By Therapeutic Application
16.4. France Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
16.4.1. Market Size and Analysis
16.4.1.1. By Revenues
16.4.2. Market Share and Analysis
16.4.2.1. By Therapeutic Application
16.5. UK Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
16.5.1. Market Size and Analysis
16.5.1.1. By Revenues
16.5.2. Market Share and Analysis
16.5.2.1. By Therapeutic Application
16.6. Russia Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
16.6.1. Market Size and Analysis
16.6.1.1. By Revenues
16.6.2. Market Share and Analysis
16.6.2.1. By Therapeutic Application
16.7. Rest of Europe Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
16.7.1. Market Size and Analysis
16.7.1.1. By Revenues
16.7.2. Market Share and Analysis
16.7.2.1. By Therapeutic Application

17. Middle East & Africa Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
17.1. Market Size and Analysis
17.1.1. By Revenues
17.2. Market Share and Analysis
17.2.1. By Therapeutic Application
17.2.2. By Country
17.2.2.1. UAE
17.2.2.2. Israel
17.2.2.3. Rest of Middle East & Africa
17.3. UAE Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
17.3.1. Market Size and Analysis
17.3.1.1. By Revenues
17.3.2. Market Share and Analysis
17.3.2.1. By Therapeutic Application
17.4. Israel Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
17.4.1. Market Size and Analysis
17.4.1.1. By Revenues
17.4.2. Market Share and Analysis
17.4.2.1. By Therapeutic Application
18. Asia-Pacific Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
18.1. Market Size and Analysis
18.1.1. By Revenues
18.2. Market Share and Analysis
18.2.1. By Component
18.2.2. By Therapeutic Application
18.2.3. By Country
18.2.3.1. China
18.2.3.2. India
18.2.3.3. Japan
18.2.3.4. Rest of Asia Pacific
18.3. China Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
18.3.1. Market Size and Analysis
18.3.1.1. By Revenues
18.3.2. Market Share and Analysis
18.3.2.1. By Therapeutic Application
18.4. India Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
18.4.1. Market Size and Analysis
18.4.1.1. By Revenues
18.4.2. Market Share and Analysis
18.4.2.1. By Therapeutic Application
18.5. Japan Artificial Intelligence (AI) Enabled Imaging Modalities Market Outlook, 2016-2026F
18.5.1. Market Size and Analysis
18.5.1.1. By Revenues
18.5.2. Market Share and Analysis
18.5.2.1. By Therapeutic Application
19. Competitive Outlook
19.1. Competition Matrix
19.1.1. Technology Portfolio
19.1.2. Brand Specialization
19.1.3. Target Markets
19.1.4. Target Technology
19.1.5. Research & Development
19.1.6. Strategic Alliances
19.1.7. Strategic Initiatives
19.2. Company Profiles (Business Description, Technology Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
19.2.1. Arterys
19.2.2. Voxel cloud
19.2.3. Butterfly network
19.2.4. Infervision
19.2.5. Gauss Surgical
19.2.6. Owkin
19.2.7. Zebra Medical vision
19.2.8. Curemetrix
19.2.9. Cellmatiq
19.2.10. MedyMatch
19.2.11. BrainerMiner
19.2.12. Lunit
20. Disclaimer